MADRID, June 14, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported data highlighting its ...
Fortress Biotech shares were trading 36% lower, at $2.35, after the company said the Food and Drug Administration issued a Complete Response Letter to its majority-owned subsidiary, Cyprium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results